Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 0.657\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a) CCc1nnc(NC(=O)CSc2nnnn2C)s1
b) CCCCCCCOC(=O)C1=C(C)Nc2ncnn2C1c1cccs1
c) Cc1cccc(CNc2ncnc3ccc(-c4ccccc4Cl)cc23)c1
d) COc1ccc(Cl)c(NC(=O)C/C(C)=N/NC(=O)CCc2ccccc2)c1
e) COc1cc(COCC(O)CN2CCN(Cc3ccccc3)CC2)cc(OC)c1OC.Cl
Answer: a. CCc1nnc(NC(=O)CSc2nnnn2C)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1nnc(NC(=O)CSc2nnnn2C)s1
CCc1nnc(NC(=O)CSc2nnnn2C)s1
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-(1-methyltetrazol-5-yl)sulfanylacetamide